Advanced diffuse malignant peritoneal mesothelioma responding to palliative chemotherapy

被引：1
|
作者：
Nakashima K. [1 ]
Inatsu H. [1 ]
Kitamura K. [1 ]
Hikosaka T. [1 ]
Hoshiko S. [1 ]
Ashiduka S. [1 ]
机构：
[1] First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki Hospital, 5200 Kihara, Kiyotake
来源：
Clinical Journal of Gastroenterology | 2012年 / 5卷 / 6期
关键词：
Chemotherapy; Cisplatin; Diffuse type; Malignant peritoneal mesothelioma; Pemetrexed;
D O I：
10.1007/s12328-012-0334-1
中图分类号：
学科分类号：
摘要：
A 64-year-old man diagnosed with advanced malignant peritoneal mesothelioma by laparoscopic biopsy was treated with systemic chemotherapy. The patient underwent first-line chemotherapy with pemetrexed plus cisplatin for 11 months, then second-line chemotherapy with gemcitabine plus vinorelbine for 6 months, and third-line chemotherapy with CPT-11 for 4 months. After third-line chemotherapy failed, he received palliative treatment. Although the tumor continued to grow, and he died 24 months after initiation of treatment, chemotherapy prolonged the survival time and improved his quality of life. © 2012 Springer Japan.
引用
收藏
页码：373 / 376
页数：3
相关论文
共 50 条
  • [41] Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma
    Yan, Tristan D.
    Brun, Erwin A.
    Cerruto, Carlos A.
    Haveric, Namik
    Chang, David
    Sugarbaker, Paul H.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (01) : 41 - 49
  • [42] Diffuse malignant peritoneal mesothelioma treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Experience of NCI of Milan
    Deraco, M.
    Kusamura, S.
    Baratti, D.
    Nonaka, D.
    Cabras, A. D.
    Zaffaroni, N.
    Casali, P.
    LUNG CANCER, 2006, 54 : S28 - S28
  • [43] Local-regional approach to diffuse malignant peritoneal mesothelioma
    Sugarbaker, Paul H.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2007, 31 (10): : 780 - 781
  • [44] Circulating CA125 and diffuse malignant peritoneal mesothelioma
    Baratti, D.
    Kusamura, S.
    Deraco, M.
    EJSO, 2009, 35 (11): : 1198 - 1199
  • [45] Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma
    Cerruto, Carlos A.
    Brun, Erwin A.
    Chang, David
    Sugarbaker, Paul H.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2006, 130 (11) : 1654 - 1661
  • [46] A Rare Case of Diffuse Peritoneal Malignant Mesothelioma in a Young Female
    Alizadeh, Y.
    Williams, B.
    Da Costa, P.
    Buxton, E. J.
    Wilkinson, N.
    JOURNAL OF PATHOLOGY, 2011, 224 : S35 - S35
  • [47] Coexistence of Diffuse Malignant Peritoneal Mesothelioma and Candida norvegensis Peritonitis
    Virgilio, Edoardo
    Mercantini, Paolo
    Ferri, Mario
    Cavallini, Marco
    Teggi, Antonella
    Ziparo, Vincenzo
    SURGICAL INFECTIONS, 2014, 15 (05) : 660 - 661
  • [48] Nivolumab activity in advanced refractory malignant peritoneal mesothelioma
    Becker, Ondine
    Beaulaton, Clement
    Masliah-Planchon, Julien
    Servois, Vincent
    Watson, Sarah
    EUROPEAN JOURNAL OF CANCER, 2021, 144 : 386 - 388
  • [49] PULMONARY ENCASEMENT - SIGN OF ADVANCED MALIGNANT DIFFUSE MESOTHELIOMA
    KENDALLSMITH, IM
    AUSTRALASIAN RADIOLOGY, 1979, 23 (01): : 24 - 29
  • [50] Chemotherapy maintenance: An option for prolonged survival in malignant peritoneal mesothelioma?
    Hofer, Silvia
    Sasse, Bernd
    Scheffel, Hans
    ACTA ONCOLOGICA, 2010, 49 (01) : 125 - 127
12345